Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Phase II Study of ONTAK (Denileukin Diftitox) in Patients With Previously-Treated Chronic Lymphocytic Leukemia

NCT00055146 is registered in ClinicalTrials.gov with Eisai Inc. as lead sponsor.

NCT NCT00055146
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00055146 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Phase II Study of ONTAK (Denileukin Diftitox) in Patients With Previously-Treated Chronic Lymphocytic Leukemia
Lead sponsor
Eisai Inc.
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2003
Completion date
May 31, 2006
Enrollment
41 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia, lymphocytic, chronic